Biological reagent catalog
    1.
    发明授权
    Biological reagent catalog 有权
    生物试剂目录

    公开(公告)号:US08412596B2

    公开(公告)日:2013-04-02

    申请号:US12650823

    申请日:2009-12-31

    IPC分类号: G06Q10/00 G06K9/46

    摘要: Embodiments relate to providing one or more recommended biological reagents in response to receiving a biological reagent order. An exemplary embodiment includes identifying biological reagents based on a biological reagent order that has been received. Characteristic data of the identified biological reagents may then be evaluated to identify a characteristic conflict among the identified biological reagents. Similarly, inventory data of the identified biological reagents may then be evaluated to identify an inventory conflict among the identified biological reagents. If a conflict, either characteristic or inventory, is identified, a recommendation for an alternative biological reagent may be provided that is free from conflict. Additionally, historical use data may be maintained and referenced to aid in identifying a biological reagent as either a potential biological reagent based on a suspected biological condition or as a substitute biological reagent.

    摘要翻译: 实施方案涉及响应于接受生物试剂顺序而提供一种或多种推荐的生物试剂。 示例性实施方案包括基于已经接收的生物试剂顺序识别生物试剂。 然后可以评估所鉴定的生物试剂的特征数据,以鉴定鉴定的生物试剂之间的特征冲突。 类似地,然后可以评估所鉴定的生物试剂的库存数据,以鉴定所识别的生物试剂之间的库存冲突。 如果确定了特征或清单之间的冲突,则可以提供不含冲突的替代生物试剂的建议。 此外,可以维护和参考历史使用数据,以帮助将生物试剂鉴定为基于可疑生物学条件的潜在生物试剂或作为替代生物试剂。

    Biological Reagent Catalog
    2.
    发明申请
    Biological Reagent Catalog 有权
    生物试剂目录

    公开(公告)号:US20110161207A1

    公开(公告)日:2011-06-30

    申请号:US12650823

    申请日:2009-12-31

    IPC分类号: G06Q10/00 G06N5/02

    摘要: Embodiments relate to providing one or more recommended biological reagents in response to receiving a biological reagent order. An exemplary embodiment includes identifying biological reagents based on a biological reagent order that has been received. Characteristic data of the identified biological reagents may then be evaluated to identify a characteristic conflict among the identified biological reagents. Similarly, inventory data of the identified biological reagents may then be evaluated to identify an inventory conflict among the identified biological reagents. If a conflict, either characteristic or inventory, is identified, a recommendation for an alternative biological reagent may be provided that is free from conflict. Additionally, historical use data may be maintained and referenced to aid in identifying a biological reagent as either a potential biological reagent based on a suspected biological condition or as a substitute biological reagent.

    摘要翻译: 实施方案涉及响应于接受生物试剂顺序而提供一种或多种推荐的生物试剂。 示例性实施方案包括基于已经接收的生物试剂顺序识别生物试剂。 然后可以评估所鉴定的生物试剂的特征数据,以鉴定鉴定的生物试剂之间的特征冲突。 类似地,然后可以评估所鉴定的生物试剂的库存数据,以鉴定所识别的生物试剂之间的库存冲突。 如果确定了特征或清单之间的冲突,则可以提供不含冲突的替代生物试剂的建议。 此外,可以维护和参考历史使用数据,以帮助将生物试剂鉴定为基于可疑生物学条件的潜在生物试剂或作为替代生物试剂。